Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-050851
Filing Date
2025-03-10
Accepted
2025-03-10 16:01:58
Documents
6
Effectiveness Date
2025-03-10

Document Format Files

Seq Description Document Type Size
1 S-8 d921527ds8.htm S-8 54921
2 EX-5.1 d921527dex51.htm EX-5.1 11709
3 EX-23.2 d921527dex232.htm EX-23.2 1942
4 EX-FILING FEES d921527dexfilingfees.htm EX-FILING FEES 20134
5 GRAPHIC g921527g24p40.jpg GRAPHIC 3070
6 GRAPHIC g921527g39y32.jpg GRAPHIC 4006
  Complete submission text file 0001193125-25-050851.txt   99820
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285677 | Film No.: 25723585
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)